Cabometyx Alternatives Compared
| Cabometyx (cabozantinib) | Lutathera (lutetium lu 177 dotatate) | Lanreotide |
|
|---|
| Cabometyx (cabozantinib) | Lutathera (lutetium lu 177 dotatate) | Lanreotide |
|
|||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Cabometyx is a multikinase inhibitor that decreases the ability of cancer cells to grow and spread and inhibits the formation of new blood vessels that supply blood and nutrients to the cancer cells... View more |
Prescription only
Prescribed for Neuroendocrine Tumors. Lutathera may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Neuroendocrine Tumors, Carcinoid Syndrome, Acromegaly. Lanreotide may also be used for purposes not listed in this medication guide. |
Related suggestions Neuroendocrine Tumors
|
|||||||||||||||||||||||
| More about Cabometyx (cabozantinib) | More about Lutathera (lutetium lu 177 dotatate) | More about Lanreotide | ||||||||||||||||||||||||
| Ratings & Reviews | ||||||||||||||||||||||||||
|
Cabometyx has an average rating of 8.4 out of 10 from a total of 12 ratings on Drugs.com. 75% of reviewers reported a positive effect, while 0% reported a negative effect. |
Lutathera has an average rating of 9.0 out of 10 from a total of 1 ratings on Drugs.com. 100% of reviewers reported a positive effect, while 0% reported a negative effect. |
Lanreotide has an average rating of 8.0 out of 10 from a total of 1 ratings on Drugs.com. 100% of reviewers reported a positive effect, while 0% reported a negative effect. |
||||||||||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||||||||||||||||||||||||||
|
View all Cabometyx side effects |
View all Lutathera side effects |
View all Lanreotide side effects |
||||||||||||||||||||||||
| Drug Class | ||||||||||||||||||||||||||
| Generic Availability | ||||||||||||||||||||||||||
|
Lower cost generic |
||||||||||||||||||||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||||||||||||||||||
View all Cabometyx prices |
View all Lutathera prices |
View all Lanreotide prices |
||||||||||||||||||||||||
| Dosage Forms | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
| Brand Names | ||||||||||||||||||||||||||
| Other cabozantinib brands include: Cometriq |
N/A |
Somatuline Depot | ||||||||||||||||||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | ||||||||||||||||||||||||||
|
99 hours |
71 hours |
720 hours |
||||||||||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | ||||||||||||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||||||||||
| Pregnancy Category | ||||||||||||||||||||||||||
|
Category D
Positive evidence of risk
See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||||||||||||||||||
| Drug Interactions | ||||||||||||||||||||||||||
|
A total of 531 drugs are known to interact with Cabometyx:
|
A total of 236 drugs are known to interact with Lutathera:
|
A total of 164 drugs are known to interact with Lanreotide:
|
||||||||||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|
||||||||||||||||||||||||
| Disease Interactions | ||||||||||||||||||||||||||
| First Approval Date | ||||||||||||||||||||||||||
|
April 25, 2016 |
N/A |
N/A |
||||||||||||||||||||||||
| WADA Class View classifications | ||||||||||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||||||||||
| More Information | ||||||||||||||||||||||||||
| Patient Resources | ||||||||||||||||||||||||||
| Professional Resources | ||||||||||||||||||||||||||
| Related Treatment Guide | ||||||||||||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Keytruda
Keytruda is used to treat multiple types of cancer such as melanoma, non-small cell lung cancer ...
Avastin
Avastin is used to brain tumors and cancers of the kidney, colon, rectum, or lung. Learn about side ...
Lutathera
Lutathera is a targeted radiotherapy used for gastroenteropancreatic neuroendocrine tumors ...
Armour Thyroid
Armour Thyroid is used for hashimoto's disease, hypothyroidism, after thyroid removal, thyroid ...
Opdivo
Opdivo is used to treat many cancers, such as melanoma, non-small cell lung cancer, malignant ...
NP Thyroid
NP Thyroid is used for hashimoto's disease, hypothyroidism, after thyroid removal, thyroid cancer ...
Lenvima
Lenvima (lenvatinib) is used to treat thyroid cancer, advanced renal cell carcinoma, hepatocellular ...
Imfinzi
Imfinzi (durvalumab) is an immunotherapy used to treat types of lung cancer (NSCLC, SCLC), bile ...
Tecentriq
Tecentriq (atezolizumab) is a monoclonal antibody used to treat non-small cell lung cancer, small ...
Adriamycin
Adriamycin is used for acute lymphoblastic leukemia, acute myeloblastic leukemia, bladder cancer ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.